Ascentage Pharma Group International (HKG:6855)

HKG:6855 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 6, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	16,113	19,230	14,071	7,772	6,636	7,264
Market Cap Growth	33.63%	36.66%	81.06%	17.11%	-8.65%	-14.53%
Enterprise Value	15,576	19,301	14,727	7,885	6,475	6,225
Last Close Price	43.78	52.25	45.45	27.30	25.70	28.20
Forward PE	-	154.05	-	-	-	-
PS Ratio	25.22	30.10	13.48	31.78	27.99	212.05
PB Ratio	10.85	12.95	48.23	99.87	14.36	4.79
P/TBV Ratio	11.74	14.01	80.87	-	19.59	5.15
EV/Sales Ratio	24.38	30.21	14.11	32.24	27.31	181.70
Debt / Equity Ratio	1.48	1.48	6.09	25.42	4.39	0.88
Net Debt / Equity Ratio	-0.37	-0.37	1.47	9.84	0.71	-0.54
Net Debt / EBITDA Ratio	0.43	0.43	-1.34	-0.85	-0.34	0.73
Net Debt / FCF Ratio	0.41	0.41	-2.96	-0.90	-0.34	0.64
Asset Turnover	0.17	0.17	0.38	0.08	0.07	0.01
Inventory Turnover	2.78	2.78	2.56	2.38	3.29	-
Quick Ratio	1.69	1.69	1.17	1.35	1.78	5.05
Current Ratio	1.79	1.79	1.26	1.44	1.86	5.22
Return on Equity (ROE)	-154.56%	-154.56%	-235.32%	-386.28%	-107.45%	-75.18%
Return on Assets (ROA)	-23.02%	-23.02%	-9.25%	-20.92%	-19.14%	-24.97%
Return on Capital Employed (ROCE)	-52.20%	-52.20%	-26.10%	-57.00%	-45.30%	-36.20%
Earnings Yield	-8.58%	-7.19%	-3.07%	-13.12%	-15.04%	-13.22%
FCF Yield	-8.30%	-6.95%	-1.03%	-10.95%	-14.60%	-17.57%
Buyback Yield / Dilution	-17.90%	-17.90%	-7.00%	-7.07%	-3.56%	-17.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.